NCT02794402View on ClinicalTrials.gov

Double-blinded, 6 Months Study With Bydureon® or Placebo in Adolescents With Obesity to Explore Changes in BMI

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 30, 2015

Primary Completion Date

September 30, 2016

Study Completion Date

November 30, 2016

Conditions

Obesity

Interventions

DRUG

Exenatide

Bydureon (Exenatide once weekly) injections s.c.

BEHAVIORAL

Placebo

Placebo once weekly injections sc

Trial Locations (2)

5020

Department of Pediatrics, Salzburg State Hospital, Paracelsus Medical University, Salzburg

75185

Uppsala University Hospital, Uppsala

All Listed Sponsors

lead

Uppsala University

OTHER

NCT02794402 - Double-blinded, 6 Months Study With Bydureon® or Placebo in Adolescents With Obesity to Explore Changes in BMI | Biotech Hunter | Biotech Hunter